Covid-19-ից մահվան՝ ԱՎԾ և ԱՆ թվերը մոտ 700-ով տարբեր են․ Քննություն է տարվում
News2021-11-25
6 Views
Նշանակված է քննություն
Source: PanARMENIAN.Net (licensed under a CC BY 3.0 License)
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
NRx Pharmaceuticals (Nasdaq: NRXP): FDA Declines Emergency Use Authorization for ZYESAMI (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir
